Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men

AIDS

Volumn 23, Issue 3, 2009, Pages 329-333

  Hasselrot, Klara ^a   Säberg, Pär ^b   Hirbod, Taha ^a   Söderlund, Johan ^a   Ehnlund, Mariethe ^a   Bratt, Göran ^b   Sandström, Eric ^b   Broiiden, Kristina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

HIV 1; LgA1; Men who have sex with men; Neutralization; Oral intercourse; Saliva

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUAL; ORAL SEXUAL CONTACT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA; SALIVA ANALYSIS; SELF REPORT; SERODIAGNOSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; COHORT STUDIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; MOUTH MUCOSA; SALIVA; SEXUAL BEHAVIOR; UNSAFE SEX;

EID: 59849117394     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32831f924c     Document Type: Article

References (22)

1. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, et al. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 1996; 272:1486- 1489.
2. Maher DM, Zhang ZQ, Schacker TW, Southern PJ. Ex vivo modeling of oral HIV transmission in human palatine tonsil. J Histochem Cytochem 2005; 53:631-642.
3. Stahl-Hennig C, Steinman RM, Tenner-Racz K, Pope M, Stolte N, Mätz-Rensing K, et al. Rapid infection of oral mucosal- associated lymphoid tissue with simian immunodeficiency virus. Science 1999; 285:1261-1265.
4. Pudney J, Oneta M, Mayer K, Seage G 3rd, Anderson D. Preejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 1992; 340:1470.
5. DeGruttola V, Mayer KH. Human immunodeficiency virus and oral intercourse. Ann Intern Med 1987; 107:428-429.
6. Goldberg DJ, Green ST, Kennedy DH, Emslie JA, Black JD. HIV and orogenital transmission. Lancet 1988; 2:1363.
7. Keet IP, Albrecht van Lent N, Sandfort TG, Coutinho RA, van Griensven GJ. Orogenital sex and the transmission of HIV among homosexual men. AIDS 1992; 6:223-226.
8. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-264.
9. Kulkarni PS, Butera ST, Duerr AC. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Rev 2003; 5:87-103.
10. Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ, et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 2008; 22:727-735.
11. Hirbod T, Reichard C, Hasselrot K, Soderlund J, Kimani J, Bwayo JJ, et al. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. Curr HIV Res 2008; 6:28-33.
12. Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, et al. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. l Acquir Immune Defic Syndr 2002; 30:413-420.
13. Carballo-Dieguez A, Remien R, Dolezal, C, Wagner G. Reliability of sexual behaviour self-reports in male couples of discordant HIV status. Journal of Sex Research 1999; http://findarticles.eom/p/articles/mi- m2372/is-02-36/ai-54882517 Accessed: 10 December 2008.
14. Wright PF, Kozlowski PA, Rybczyk GK, Goepfert P, Staats HF, VanCott TC, et al. Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2002; 18:1291-1300.
15. Bouhlal H, Hocini H, Quillent-Grégoire C, Donkova V, Rose S, Amara A, et al. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J Immunol 2001; 166:7606-7611.
16. Wright A, Yan H, Lamm ME, Huang YT. Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells. Virology 2006; 356: 165-170.
17. Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, Morris L, et al. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccinesj Virol 2005; 79:10103-10107.
18. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005; 79:10108-10125.
19. Polonis VR, Brown BK, Borges AR, Zolla-Pazner S, Dimitrov DS, Zhang MY, et al. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008; 375:315-320.
20. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee S, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol 1997; 146:531-542.
21. Bratt GA, Berglund T, Glantzberg BL, Albert J, Sandstrom E. Two cases of oral-to-genital HIV-1 transmission. Int J STD AIDS 1997; 8:522-525.
22. Rothenberg RB, Scarlett M, del Rio C, Reznik D, O'Daniels C. Oral transmission of HIV. AIDS 1998; 12:2095-2105.